Media coverage about Centene (NYSE:CNC) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Centene earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave media coverage about the company an impact score of 45.8924831693245 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the headlines that may have effected Accern’s scoring:

Shares of Centene (NYSE:CNC) traded down $1.22 during trading hours on Wednesday, hitting $98.51. 1,062,551 shares of the company were exchanged, compared to its average volume of 1,682,552. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 0.71. Centene has a twelve month low of $54.40 and a twelve month high of $103.15. The company has a market cap of $16,970.00, a P/E ratio of 18.72, a PEG ratio of 1.50 and a beta of 0.71.

Centene (NYSE:CNC) last posted its earnings results on Tuesday, October 24th. The company reported $1.35 EPS for the quarter, topping the consensus estimate of $1.24 by $0.11. Centene had a net margin of 1.81% and a return on equity of 14.79%. The firm had revenue of $11.90 billion during the quarter, compared to analysts’ expectations of $11.75 billion. During the same quarter in the prior year, the firm earned $1.12 EPS. Centene’s quarterly revenue was up 9.7% on a year-over-year basis. analysts expect that Centene will post 4.98 earnings per share for the current fiscal year.

CNC has been the topic of a number of recent analyst reports. BidaskClub upgraded shares of Centene from a “hold” rating to a “buy” rating in a research note on Thursday, August 24th. Piper Jaffray Companies restated a “buy” rating and issued a $105.00 target price on shares of Centene in a research note on Friday, September 1st. Cantor Fitzgerald upped their target price on shares of Centene to $107.00 and gave the company an “overweight” rating in a research note on Wednesday, September 13th. Cowen restated an “outperform” rating and issued a $105.00 target price (up previously from $77.00) on shares of Centene in a research note on Wednesday, September 13th. Finally, Leerink Swann restated a “market perform” rating and issued a $90.00 target price (up previously from $78.00) on shares of Centene in a research note on Wednesday, September 13th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have given a buy rating to the company’s stock. Centene currently has a consensus rating of “Buy” and an average target price of $99.11.

In other Centene news, Director Robert K. Ditmore sold 4,167 shares of the company’s stock in a transaction dated Thursday, October 26th. The shares were sold at an average price of $90.42, for a total value of $376,780.14. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 3.00% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “Centene (CNC) Getting Somewhat Positive Press Coverage, Analysis Finds” was originally published by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at

Centene Company Profile

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Insider Buying and Selling by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.